A Danish biopharmaceutical company and the University of Copenhagen, Denmark, have set up the MicroRNA Research Consortium, with funding from the Danish Advanced Technology Foundation.
A spin-out from Oxford University is looking to attract the attention of equity investors and pharmaceutical companies by focusing on the discovery and development of small molecules to treat cancer
A spin-out from Sheffield that uses stem cells to help with conventional drug discovery is looking for investment to continue pre-clinical research on therapeutic applications and business development activities.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.